Objectives: Animal models of vaginal distention (VD) have demonstrated increased expression of chemokine (C-C motif ) ligand 7 (CCL7) In this study, we investigated the expression of CCL7 in mice models of simulated birth traumaYinduced urinary incontinence using VD and pudendal nerve transection (PNT).
U rinary incontinence is among the most prevalent conditions of the pelvic floor disorder, affecting 38% to 41% of adult women in the United States and the Western world. 1 Stress urinary incontinence (SUI) accounts for nearly half of all cases and can cause significant declines in quality of life. 2 Although the pathophysiological mechanisms involved in the development of SUI are not fully elucidated, the body of epidemiological evidence describes a key inciting role of vaginal delivery in its development. Vaginal childbirth can injure the nerve, muscle, and collagenous tissues responsible for maintaining continence. 3 To explore the role of vaginal delivery in the development of SUI, rodent models of simulated maternal childbirth injury have been developed, using vaginal distention (VD), 4Y7 pudendal nerve crush, bilateral pudendal nerve transection (PNT), and pubourethral ligament transection. 5, 8, 9 Vaginal distention mimics the nonspecific trauma associated with the second stage of labor in women, whereas pudendal nerve crush and PNT aim to simulate the nerve injury observed with vaginal delivery directly. All of these models, either alone or in combination, result in a significant decrease in urethral resistance to leakage, indicative of SUI. 10Y13 We have shown that a substantial decrease in leak point pressure 4 days after VD with near complete recovery to baseline within 14 days has been shown in rats. 14 Pudendal nerve transection has been shown to produce long-lasting reductions in leak point pressure, up to 5 weeks after nerve transection in rats. 15 Furthermore, VD has been shown to alter urethral tissue as early as 1 hour after injury and external urethral sphincter within 4 hours. 6 Stem cell therapies are among the newest strategies under investigation for the treatment and prevention of SUI. 16 Direct localized injection 17, 18 and targeted stem cell homing 19Y21 are potential modalities that may one day be used to treat the symptoms of SUI. Injuries, such as myocardial infarction or VD, cause increases in local expression of stem cell homing cytokines such as chemokine (C-C motif ) ligand 7 (CCL7; formerly monocyte chemotactic protein-3 [CCL7] and stromal derived factor-1 (SDF-1), which in turn stimulate homing of hematopoietic and mesenchymal stem cells. 19Y27 The resultant cytokine gradient recruits hematopoietic stem cells and mesenchymal stem cells to the injured area, where they engraft, produce growth factors, facilitate healing from injury, and improve functional recovery. 22 Thus, facilitation or duplication of endogenous stem cell homing may represent a method to enhance the benefits of stem cell treatment for SUI.
As a step toward development of such a treatment, we aim to further our understanding of the role of CCL7 in VD using a recently validated mouse model. 28Y30 Using this model, we previously demonstrated a decrease in urethral resistance to leakage, disruption of the external urethral sphincter after VD, and changes in CCL7 levels in obese mice. 27 The aims of this study were to evaluate the expression of the stem cell homing factor, CCL7, in a validated VD mouse model; to determine if isolated pudendal nerve injury contributes to the CCL7 response; and to determine if the local expression of CCL7 is associated with a systemic response after injury. Relative quantity (RQ) of CCL7 gene expression in C57BL mice immediately and 24 hours after injury in urethra (A), vagina (B), and rectum (C). Anesth, anesthesia alone. Threshold cycle value of each sample for target gene was normalized to GAPDH and relative quantity of messenger RNA level was calculated. Data represent a mean T SD of 3 to 5 animals per group of the relative expression of CCL7 normalized to the mean of the control group. A one-way analysis of variance was performed to determine differences in relative expressions or concentrations of CCL7 between controls versus each of the 10 study groups. Adjustment for multiple testing was done using the Dunnett method. All tests were performed on log-transformed data to stabilize the variance. Analysis was repeated in each of 4 locations. P G 0.05 was considered statistically significant. All analyses were done using the statistical program R, version 2.11 (Vienna, Austria). *P G 0.05; †P G 0.01. group): age-matched control (no surgery, no anesthesia, 4 mice), anesthesia only (ketamine [100-mg/kg body weight] and xylazine [10-mg/kg body weight] administered intraperitoneally), or anesthesia plus either VD, sham VD, bilateral PNT, or sham bilateral PNT. Details of simulated birth trauma (VD or PNT) or sham surgeries are provided below. Testing was performed either immediately or 24 hours after all procedures. Whole blood samples (0.5 mL) were obtained for enzyme-linked immunosorbent assay (ELISA) quantification of serum CCL7 levels. Mice were killed using urethane, 1.2 g/kg, administered intraperitoneally. Pelvic tissues (urethral, vaginal, and rectal tissues) were harvested for quantitative real-time (RT) polymerase chain reaction (PCR) (RT-PCR) quantification. All experimental protocols and procedures were approved by the Institutional Animal Care and Use Committees at the Cleveland Clinic and Case Western Reserve University.
Vaginal Distension (VD)
To avoid rupturing the vagina, vaginal accommodation with urethral dilators was achieved by sequentially inserting and removing increasing sizes of urethral dilators (8Y16 F) as they were lubricated with Surgilube (Fougera, Melville, NY). 4Y6,29 Then, a modified 6-F Foley catheter was lubricated and inserted into the vagina and secured to the vaginal introitus with a 5-0 silk suture. Next, we infused 0.3 mL of distilled water into the balloon to distend the vagina. After 1 hour, the balloon was deflated and removed, and the animal was allowed to awaken from the anesthesia spontaneously. Mice in the sham distension group were anesthetized and were only subjected to the vaginal accommodation of the urethral dilators, followed by insertion of the uninflated 6-F Foley catheter. The anesthesia only and control groups did not undergo VD or insertion of the catheter.
Pudendal Nerve Transection (PNT)
Mice were prepared for aseptic surgery. From a dorsal longitudinal incision, the ischiorectal fossa was opened bilaterally. Using loop magnification, the pudendal nerve was isolated and transected. A small section of the pudendal nerve was removed on both sides to ensure no nerve regeneration occurred. The incision was then closed in layers using 4-0 vicryl for the muscles and 6-0 vicryl for the skin. In the sham PNT group, all mice underwent dorsal longitudinal incision after ischiorectal fossa opening and closing without injury to the pudendal nerve.
Tissue Preparation and RT-PCR Quantification of MCP3
Pelvic dissection was performed in all mice; and the urethra, vaginal wall, and rectal wall were harvested and immediately immersed in RNA later stabilization reagent (Qiagen, Valencia, Calif ) and kept at j80-C. Total RNA was isolated from the frozen tissues using an RNeasy fibrous tissue mini RNA isolation kit following the manufacturer's instructions (Qiagen). RNA concentration was determined with NanoDrop-1000 spectrophotometer. Contaminated DNA was removed by RNase-Free DNase Set (Qiagen), and reverse transcription reaction was performed in 50 KL of reaction volume with 2 Kg of total RNA using high-capacity cDNA reverse transcription kits (Applied Biosystems, Foster City, Calif ). Quantitative RT-PCR was performed to determine the relative expression of CCL7 using Applied Biosystems 7500 real-time PCR system (Applied Biosystems).
Forty nanograms of input cDNA was used in triplicate with primer sets for a housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) primer (Invitrogen, Carlsbad, Calif ) sequences: GAPDH Forward: 5 ¶-CCC CTG GCC AAG GTC ATC CA-3 ¶, GAPDH Reverse: 5 ¶-CGG AAG GCC ATG CCA GTG AG-3 ¶) and the target gene CCL7 primer (Invitrogen) sequences: CCL7 Forward: 5 ¶-AAG ATC CCC AAG AGG AAT CTC AAG-3 ¶, CCL7 Reverse: 5 ¶-CAG ACT TCC ATG CCC TTC TTT G-3 ¶) for SYBR green quantitative RT-PCR (Invitrogen). Cycle conditions were as follows: 50-C held for 2 minutes, 95-C held for 10 minutes, 40 cycles of 95-C for 15 seconds, and 60-C for 1 minute.
Threshold cycle value of each sample for target gene was normalized to glyceraldehydes 3-phosphate dehydrogenase (GAPDH) and relative quantity of messenger RNA level was calculated. CCL7 levels measured in the experiment groups were first normalized to GAPDH and then compared to values measured in the control group. Quantitative data were presented as the mean and standard deviation of the relative expression of CCL7 normalized to the mean of the control group.
ELISA Quantification of Blood Serum CCL7
Serum analysis was performed using the Mouse CCL7 Instant ELISA (Bender MedSystems, Vienna, Austria). Whole blood samples (0.5 mL) obtained from mice via the heart were centrifuged at 2000g for 15 minutes at 4-C. Serum layer was extracted and stored at j80-C. Before analysis, serum samples were slowly warmed to room temperature. One hundred microliters of distilled water was added to all sample wells, as well as standard wells (to produce a concentration gradient of 1000, 500, 250, 125, 63, 32, and 16 pg/mL) and blank wells. Fifty microliters of serum were added to sample wells with all samples run in duplicate. The 96-well plate was incubated at room temperature for 3 hours followed by 4 exchanges with wash buffer. Afterward, 100 KL of substrate solution was added to all wells, and the plate was incubated at room temperature for 10 minutes. Stop solution (100 KL; provided in the kit) was added to all wells once the highest standard reached a dark blue color. The plate was read on a Victor 2V multilabel counter (PerkinElmer, Waltham, Mass) at 450 nm.
Statistical Analysis
The relative expression of CCL7 in urethra, rectum, and vagina and the blood concentration of CCL7 were described as mean T SD. A one-way analysis of variance was performed to determine differences in relative expressions or concentrations of CCL7 between controls versus each of the 10 study groups (Anes0h, Anes24h, shamVD0h, shamVD24h, VD0h, VD24h, sham PNT0h, sham PNT24h, PNT0h, and PNT24h). Adjustment for multiple testing was done using the Dunnett method. All tests were performed on log-transformed data to stabilize the variance. Analysis was repeated in each of 4 locations: urethra, rectum, vagina, and blood. P G 0.05 was considered statistically significant. All analyses were done using the statistical program R, version 2.11 (Vienna, Austria).
RESULTS
Compared with the controls, urethral CCL7 expression was higher immediately (adjusted P = 0.08) and 24 hours (adjusted P G 0.01) after VD (Fig. 1A) . Relative CCL7 expression was 3 times as high as that of the control mice immediately after VD, rising to expression levels 13.6 times as great as that of the controls at 24 hours. Urethral expression of CCL7 was similar to that of the control mice immediately and 24 hours after in the PNT, sham VD, sham PNT, and anesthesia alone groups. Vaginal expression of CCL7 was similar across groups immediately after procedures (Fig. 1B) . Compared with the controls, vaginal CCL7 expression was significantly higher 24 hours after sham PNT (adjusted P = 0.02). Rectal expression of CCL7 was similar across groups immediately after the procedures (Fig. 1C ). Relative CCL7 expression in the rectum was 3 times as high as that of the control mice 24 hours after VD, although this difference was not statistically significant (adjusted P = 0.08). Compared with that of the controls, rectal CCL7 expression was significantly lower 24 hours after sham PNT (adjusted P = 0.04).
Serum CCL7 levels were significantly higher than those of the controls 24 hours after VD and PNT (adjusted P G 0.01 for both; Table 1 ). In the sham PNT group, serum CCL7 levels were significantly higher immediately and 24 hours after sham surgery compared with those in the controls (adjusted P = 0.04 and P G 0.01, respectively).
DISCUSSION
Mesenchymal stem cell and hematopoietic stem cells are involved in regeneration of normal and injured tissues because of their unique properties to self-renew and to home and mobilize to the site of injury, respectively. 31, 32 The biological signals directing stem cell trafficking in response to injury are the subject of much research in multiple models of tissue injury. These chemoattractants function as homing molecules that signal stem cells to migrate, differentiate, and promote subsequent tissue repair in multiple organ systems. 19Y27 After an injury, these normally quiescent cells become activated and are directed toward the damaged tissue site through specific chemical signals. 19Y26 The chemoattractants CCL7 and SDF-1 were first identified in a model of myocardial infarction and shown to facilitate functional recovery 22 and have since been identified in additional injury models. 33 The development of SUI in rat models of simulated birth trauma using VD also suggests ischemic injury as a contributing factor. 7, 34 Vaginal distention results in a significant decrease in blood flow to the urethra with a subsequent 3-fold increase in blood flow immediately after the deflation of the Foley catheter, suggestive of ischemia and reperfusion injury. 34 Up-regulation of CCL7 after VD has been shown in several rat and mice models. 20, 21, 29 The current study was therefore conducted to further explore this relationship between birth trauma injury and changes in CCL7 expression. Vaginal distention is a complex nonspecific injury model with contributions from shearing (damage inflected as tissue slides over other tissue, in this case, from the passage of the child's head and/or the placenta through the birth canal), ischemia, and potentially neuronal damage. Specifically, we aimed to determine the relative contribution of the neuronal injury component of VD to changes in CCL7 expression.
Similar to previous results in a rat model of VD, 20 our current study in mice demonstrated urethral overexpression of CCL7 immediately and 24 hours after VD; however, changes in urethral CCL7 were not observed in the PNT group at any time point. A differential response of urethral CCL7 expression after VD and PNT is not surprising given the lack of continence recovery observed with PNT compared with VD. 14, 15 Furthermore, these data suggest that a shear event (as occurs in the VD group), and not nerve injury only (as in the PNT model), may contribute to the observed changes in urethral CCL7 after VD. The theory of shear effect is supported by the lack of changes in SDF-1, a known marker of ischemia, and hypoxia-inducible factor-1 alpha previously reported in other rodent VD models. 20, 21 Although analysis of SDF-1 was not included in our study, evaluation of CCL7 levels in mice that undergo both VD and PNT would be required to confirm the exact mechanistic role each type of injury plays on CCL7 levels.
Chemokine (C-C motif ) ligand 7 expression was similar across most groups in the vagina and the rectum, with the exception of the sham PNT group. The cause of the changes observed in the sham PNT group remain unspecified at this time and further studies are warranted. Based on our previous experience with the VD model, we know that the vagina is definitely injured through stretch or lacerations, which disrupt the integrity of the vagina. However, we observed inconsistencies in the changes in CCL7 expression levels. Wood et al 21 found a positive correlation between duration of VD (up to 6 hours) and CCL7 expression in the rectal tissue harvested immediately after VD; however, Woo et al 20 did not observe differences in the rectum at any time point. Furthermore, Woo reported increased CCL7 expression in vaginal tissue. 20 Importantly, similar to our study, Woo and Wood consistently showed up-regulation of CCL7 in the urethra despite the differences observed in vaginal and rectal expressions, and increased expression in the urethra has been consistently shown across small animal species and strains. 35 In our current study, animals only underwent 1 hour of VD and tissue was harvested either immediately or 24 hours later. Although earlier studies support rapid changes in CCL7 levels after VD in some tissues, recent data from Salcedo et al 33 suggested that 24 hours may not be long enough to detect changes in cytokines after injury. Finally, the walls of the vagina and the rectum are more resistant to stretching and have an abundant blood supply compared with the urethra, therefore potentially reducing their risk of ischemic or shear injury. This rich vascularity may play a protective role through more rapid reperfusion. Therefore, in contrast to our current study, it is possible that the prolonged VD exposure in the earlier studies increased Three to 5 mice were used per treatment group and time period. Enzyme-linked immunosorbent assay quantification of serum CCL7 levels were analyzed on a Victor 2V multilabel counter at 450 nm. Data represent a mean T SD of 3 to 5 animals per group. The relative expression of CCL7 in urethra, rectum, and vagina and the blood concentration of CCL7 were described as mean T SD. A one-way analysis of variance was performed to determine differences in relative expressions or concentrations of CCL7 between controls versus each of the 10 study groups (Anes0h, Anes24h, shamVD0h, shamVD24h, VD0h, VD24h, sham PNT0h, sham PNT24h, PNT0h, and PNT24h). Adjustment for multiple testing was done using the Dunnett method. All tests were performed on log-transformed data to stabilize the variance. Analysis was repeated in each of 4 locations: urethra, rectum, vagina, and blood. P G 0.05 was considered statistically significant. All analyses were done using the statistical program R version 2.11 (Vienna, Austria).
*P e 0.01 compared with control mice. the susceptibility of these resistant tissues to damage. Taken together, these data suggest that additional time points and duration of VD are necessary to fully evaluate the effects in tissues other than the urethra. In addition, histological evaluation of each tissue and measurement of SDF-1 may provide insight into the role of ischemia and/or reperfusion in each tissue. Furthermore, the observed changes in the sham PNT group may be a result of inherent variability of the tissue sample and chemokine measured with RT-PCR technology. Immunohistochemistry has not been performed successfully on secreted molecules such as CCL7; and therefore, ELISA technologies were used to confirm the results observed with RT-PCR. Further proteinlevel confirmation of CCL7 will be conducted in the next phase of study. Analysis of serum in our study demonstrated elevated CCL7 levels after VD and PNT. Both the sham PNT and PNT groups demonstrated overexpression patterns of CCL7 in serum and with no changes in the urethra. Taken together, this therefore suggests that the observed up-regulation in the serum CCL7 level with the PNT/sham PNT is secondary to the local tissue injury of the surgical procedure itself (incision of skin and dissection of the ischiorectal fossa). The finding of overexpression of CCL7 in the serum with VD, which does not involve surgical incision and tissue dissection, could be attributed to the VD itself, and thus could potentially be used as a serum marker of injury.
Research in our laboratory is currently underway to correlate serum levels with duration and severity of injury after VD. We also plan to measure protein levels of CCL7 in tissue to confirm if the observed changes in RNA expression correlate with protein changes.
Using 2 different rodent models of SUI, this study demonstrated urethral overexpression of CCL7 after VD but not after the PNT model of isolated nerve injury. These data support the hypothesis that the observed overexpression with VD is secondary to ischemic and shear injuries. Whereas tissue-level changes varied between urethra, vagina, and rectum, the overexpression of CCL7 in the serum of mice after VD suggests a translational potential, where CCL7 measurement could be used as a surrogate for injury after delivery. Our group has recently initiated a large epidemiologic study that will include measurement of CCL7, among other chemokines, during, immediately after, and up to 12 months after delivery to determine if the findings in animal models correlate with clinical observations in postpartum women.
